Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muzafar A Macha

Showing results (21-30 of 81) with videos related to

Pageof 9
Sort By:
Journal of the National Cancer Institute|January 8, 2019
Immunometabolic Alterations by HPV Infection: New Dimensions to Head and Neck Cancer DisparitySanjib Chaudhary, Koelina Ganguly, Sakthivel Muniyan, et al.
Molecular Oncology|November 4, 2015
The canonical Wnt pathway regulates the metastasis-promoting mucin MUC4 in pancreatic ductal adenocarcinomaPriya Pai, Satyanarayana Rachagani, Imayavaramban Lakshmanan, et al.
Advances in Protein Chemistry and Structural Biology|November 27, 2025
p53 Aggregation in cancer: Molecular mechanisms, functional disruptions, and targeted therapiesAsma Shah, Sara K AlMarzooqi, Sameer Mirza, et al.
Head & Neck|July 24, 2010
Prognostic significance of nuclear pSTAT3 in oral cancerMuzafar A Macha, Ajay Matta, Jatinder Kaur, et al.
International Journal of Clinical Oncology|June 10, 2014
Combination of MUC1 and MUC4 expression predicts clinical outcome in patients with oral squamous cell carcinomaYoshiaki Kamikawa, Yuji Kanmura, Tomofumi Hamada, et al.
Medcomm|September 19, 2025
G Protein-Coupled Receptor Signaling: Implications and Therapeutic Development Advances in CancersInamu Rashid Khan, Sana Khurshid, Saud Almawash, et al.
Oncotarget|October 31, 2015
Changes in microRNA (miRNA) expression during pancreatic cancer development and progression in a genetically engineered KrasG12D;Pdx1-Cre mouse (KC) modelSatyanarayana Rachagani, Muzafar A Macha, Melanie S Menning, et al.
Translational Oncology|November 6, 2023
Epigenetic modifications: Key players in cancer heterogeneity and drug resistanceHana Q Sadida, Alanoud Abdulla, Sara Al Marzooqi, et al.
Nutrition and Cancer|April 15, 2020
Therapeutic Effects of Curcumol in Several Diseases; An OverviewSheema Hashem, Sabah Nisar, Geetanjali Sageena, et al.
Discover Oncology|May 6, 2025
Human papilloma virus infection drives unique metabolic and immune profiles in head and neck and cervical cancers: implications for targeted therapies and prognostic markersSaira Hamid, Mohd Shahnawaz Khan, Meraj Alam Khan, et al.
Pageof 9

Showing results (21-30 of 81) with videos related to

Sort By:
Pageof 9
Journal of the National Cancer Institute|January 8, 2019
Immunometabolic Alterations by HPV Infection: New Dimensions to Head and Neck Cancer DisparitySanjib Chaudhary, Koelina Ganguly, Sakthivel Muniyan, et al.
Molecular Oncology|November 4, 2015
The canonical Wnt pathway regulates the metastasis-promoting mucin MUC4 in pancreatic ductal adenocarcinomaPriya Pai, Satyanarayana Rachagani, Imayavaramban Lakshmanan, et al.
Advances in Protein Chemistry and Structural Biology|November 27, 2025
p53 Aggregation in cancer: Molecular mechanisms, functional disruptions, and targeted therapiesAsma Shah, Sara K AlMarzooqi, Sameer Mirza, et al.
Head & Neck|July 24, 2010
Prognostic significance of nuclear pSTAT3 in oral cancerMuzafar A Macha, Ajay Matta, Jatinder Kaur, et al.
International Journal of Clinical Oncology|June 10, 2014
Combination of MUC1 and MUC4 expression predicts clinical outcome in patients with oral squamous cell carcinomaYoshiaki Kamikawa, Yuji Kanmura, Tomofumi Hamada, et al.
Medcomm|September 19, 2025
G Protein-Coupled Receptor Signaling: Implications and Therapeutic Development Advances in CancersInamu Rashid Khan, Sana Khurshid, Saud Almawash, et al.
Oncotarget|October 31, 2015
Changes in microRNA (miRNA) expression during pancreatic cancer development and progression in a genetically engineered KrasG12D;Pdx1-Cre mouse (KC) modelSatyanarayana Rachagani, Muzafar A Macha, Melanie S Menning, et al.
Translational Oncology|November 6, 2023
Epigenetic modifications: Key players in cancer heterogeneity and drug resistanceHana Q Sadida, Alanoud Abdulla, Sara Al Marzooqi, et al.
Nutrition and Cancer|April 15, 2020
Therapeutic Effects of Curcumol in Several Diseases; An OverviewSheema Hashem, Sabah Nisar, Geetanjali Sageena, et al.
Discover Oncology|May 6, 2025
Human papilloma virus infection drives unique metabolic and immune profiles in head and neck and cervical cancers: implications for targeted therapies and prognostic markersSaira Hamid, Mohd Shahnawaz Khan, Meraj Alam Khan, et al.
Pageof 9